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EchocardiographyBackground:Detection of concurrent diastolic dysfunction (DD)may be beneﬁcial in patients with persistent and
longstanding persistent atrial ﬁbrillation (AF). The role of transthoracic echocardiography (TTE) in assessing DD
in patients with AF has not been well characterized. We sought to determine the utility of TTE in detecting
elevated left atrial pressure (LAP) in patients with persistent and longstanding persistent non-valvular AF
using directly measured LAP as the reference standard.
Methods: We retrospectively studied 157 patients with persistent AF and preserved left ventricular ejection
fraction who underwent pulmonary vein isolation (PVI). LAP was determined in conjunction with trans-septal
puncture at the time of catheter ablation. TTE was performed 1 day after PVI and included two dimensional,
pulse wave spectral Doppler and tissue Doppler assessments.
Results: The clinical parameter that strongly correlated with elevated LAP is longstanding persistent AF. Four
strongest TTE parameters identiﬁed to moderately correlate with LAP include 1. left atrial minimum volume
(LAVmin), 2. peak velocity of early mitral diastolic inﬂow velocity (E), 3. pulmonary vein systolic ﬂow
velocity (PVS), and 4. ratio of early diastolic transmitral inﬂow velocity to mitral annular velocity at the lateral
site (E/E′ lateral).
Conclusion: Accurate assessment of diastolic dysfunction in patients with persistent and longstanding persistent
AF is difﬁcult using TTE. A combination of LAVmin, PVS, and E might be helpful to determine elevated LAP.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Atrial ﬁbrillation (AF) and heart failure (HF) are among the most
common cardiac diseases encountered in clinical practice, and their in-
cidence is rising as the population ages. Patients with concurrent AF and
chronic HF, including those with preserved ejection fraction, have
worse prognosis than patients with AF alone [1,2]. Accurate diagnosis
of coexisting diseases is essential to the initiation of appropriate
therapies. Recent studies have demonstrated the importance of early; LAP, left atrial pressure; RFA,
ocardiography; LA, left atrium;
xed left atrial volume; E, early
, pulmonary vein systolic ﬂow
ty; E/E′, ratio of early peak
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osztoczy Foundation, Avondale,
d Ltd. This is an open access article udetection of diastolic dysfunction (DD) in patients with persistent and
longstanding persistent AF [3–6]. Transthoracic echocardiography
(TTE) is routinely used in the evaluation of diastolic function, but its util-
ity in detecting DD in patients with persistent and longstanding persis-
tent AF has not been well characterized. The ventricular ﬁlling index, or
the ratio of early diastolic transmitral velocity E and early diastolic tissue
Doppler velocity of themitral annulus E/E′, is one of the commonly used
TTE parameters that is sensitive for detection of elevated left atrial pres-
sure (LAP) in patients with preserved ejection fraction [7,8]. There is
work to suggest that E/E′may also be sensitive for the detection of ele-
vated LAP in a small cohort of 27 non-valvular AF patients; E/E′ septal
≥11 predicts elevated LV ﬁlling pressure (≥15 mm Hg) with sensitivity
of 75% and speciﬁcity of 93% [9]. E/E′ also correlated with symptomatic
HF in AF patients with preserved ejection fraction (EF) and E/E′
decreasedwith symptomatic improvement [10]. However, the potential
role of other routinely used TTE parameters of diastolic function in
detecting elevated LAP in patients with AF is not clear. Therefore, we
sought to determine the utility of two dimensional (2D), pulsed wave
spectral Doppler (PWD), and tissue Doppler imaging (TDI) echocardio-
graphic parameters in detecting elevated LAP in a large cohort ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Baseline characteristics of patients.
Characteristics Total (n = 157)
Demographics and comorbidities
Age (years) 60.6 ± 8.7
BSA (m2) 2.2 ± 0.2
Gender (% male) 82
Hypertension (%) 67
Diabetes mellitus (%) 17
Stroke (%) 6
LVEF (%) 61.4 ± 6.6
Coronary artery disease (%) 13
History of heart failure (%) 3
Pacemaker or ICD (%) 3
Asthma, COPD (%) 8
Obstructive sleep apnea (%) 26






Angiotensin receptor blocker 12
Diuretic 26
Inhaled Beta agonist 3
Beta blocker 40
AAD Class I. 31
AAD Class III. 70
AAD Class IV. 22
Digoxin 16
Abbreviations: LVEF = left ventricular ejection fraction, ICD = implantable
cardioverter-deﬁbrillator, COPD = chronic obstructive pulmonary disease, ACE =
angiotensin converting enzyme, ARB = angiotensin receptor blocker, AAD =
anti-arrhythmic drug.
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using directly measured LAP as the reference standard.
2. Methods
2.1. Study population
The study protocol was approved by the Institutional Review Board
at our institution with waiver of consent for retrospective review of
existing clinical images. There were 493 patients with drug refractory
persistent and longstanding persistent AF who underwent pulmonary
vein isolation (PVI) by radiofrequency catheter ablation at our institu-
tion between April 2009 and April 2011. The patients were excluded
from analysis if they had previous catheter ablation (251 patients), a
history of open heart surgery (17 patients), moderate or severe mitral
regurgitation (14 patients), reduced left ventricular (LV) ejection frac-
tion (EF) (b50%, 30 patients), mitral annular calciﬁcation (5 patients),
pacemaker dependency (4 patients), were in AF at time of TTE (7 pa-
tients), and no left atrial (LA) pressure registration (25 patients). Of
the remaining 157 patients with chronic AF, 121 had persistent AF,
deﬁned as continuous AF for greater than 7 days or cardioversion after
48 h of continuous AF [11], and 36 had longstanding persistent AF,
deﬁned as continuous AF for greater than 12 months [11]. Clinical data
were obtained by reviewing medical records.
2.2. Echocardiography
All patients underwent routine clinical TTE examinations including
M-mode, 2D, PWD and TDI on the ﬁrst post-procedural day following
PVI using commercially available echocardiographic machines (Vivid
7; GE Healthcare Technologies, Waukesha, Wisconsin, USA or iE33,
Philips Health Care, the Netherlands). All studies were analyzed in a
blinded fashion on dedicated workstations (ProSolv CardioVascular
Client version 4.0.4). LA diameter (LAD) was assessed in the parasternal
long-axis view (PLAX). LA area (LAA) and LA length (LAL) were
measured in the apical 4-chamber view (4C) and apical 2-chamber
view (2C). LA volume (LAV) was derived using the biplane area–length
method. Both LAA and LAV were measured at LV end-systole (LA
maximum volume (LAVmax); LA maximum area (LAAmax)) and at LV
end-diastole (LA minimum volume (LAVmin); LA minimum area
(LAAmin)). LA volume index (LAVi) was calculated based on body sur-
face area (BSA). Mitral inﬂowmeasurements using PWD included peak
early ﬂow velocity (E) and deceleration time of early mitral ﬂow veloc-
ity (DT). Peak late mitral inﬂow velocity was not measured due to the
diminutive atrial contraction post ablation. Pulmonary venous ﬂow on
PWD was characterized by peak systolic ﬂow velocity (PVS), peak
diastolic ﬂow velocity (PVD) and systolic ﬁlling fraction or the ratio of
PVS to PVD (PVSD). TDI using spectral Doppler including early velocities
from the septal and lateral mitral annulus (E′ septal and E′ lat respec-
tively) was obtained from the apical 4C view. E/E′ was calculated for
both lateral and septal annular sites (E/E′ lateral and E/E′ septal respec-
tively) and was also averaged between the two sites (E/E′ average).
2.3. Catheter ablation and left atrial pressure recordings
PVI was performed per routine at our institution as previously
described [12,13]. Brieﬂy, multipolar catheters were placed in the coro-
nary sinus and posterior right atrium (RA) and a diagnostic intracardiac
ultrasound catheter was advanced to the RA. Two trans-septal punc-
tures were performed throughwhich the ablation and circularmapping
catheters were advanced into the LA. A bolus of unfractionated heparin
was administered prior to the ﬁrst trans-septal puncture and infusion
was titrated to maintain activated clotting time between 350 and
400 s for the duration of the procedure. Immediately after the trans-
septal access, the LA pressure was transduced through the trans-septal
needle. LA x-wave pressure nadir, LA peak v-wave pressure, and meanLA pressure were recorded using an electrophysiologic recording
system (Prucka-GE, Houston, TX, USA). Elevated LAP was deﬁned as
mean LAP equal to or greater than 15 mm Hg. All patients underwent
antral PVI [13].
2.4. Statistical analysis
Statistical analyses were performed using STATA software (version
10, StataCorp, Texas, USA). Continuous variables were expressed as
mean ± standard deviation and categorical variables were expressed
as percentages. Relationship between mean LAP and TTE parameters
were evaluated using univariate linear regression analysis followed by
multiple linear regression. Potential determinants of elevated LAP
were identiﬁed by univariate logistic regression analysis and all identi-
ﬁed parameters were entered into multiple logistic regression.
Comparison of data between the normal and elevated LAP groups was
performed by use of a two-tailed, unpaired Student's t test. p values of
b0.05 were considered statistically signiﬁcant.
2.5. Reproducibility
Fifteen randomly selected studies were read by two independent
blinded observers to assessing inter-observer variability. The same
studies were re-interpreted by the ﬁrst reader in a blinded fashion 3
months after the initial reading to assess intra-observer variability.
3. Results
3.1. Baseline clinical characteristics
Baseline patient characteristics are shown in Table 1. The patients'
mean age was 60.6± 8.7 years (range 36 to 78 years). This group of pa-
tients is predominantly male and hypertensive. Seventy-seven percent
of patients had persistent AF, whereas 23% had longstanding persistent
AF. All patients had preserved LVEF (≥50%).
Table 3
Correlation between echocardiographic parameters and mean left atrial pressure.




p Value p Value
2D
LA diameter (mm) 0.14
LAA maximum (4C, cm2) 0.01
LAA minimum (4C, cm2) 0.008
LA max. length (4C, cm) 0.09
LA min length (4C, cm) 0.29
LAA maximum (2C, cm2) 0.03
LAA area minimum (2C, cm2) 0.004
LA max. length (2C, cm) 0.02
LA min length (2C, cm) 0.01
LAVmax (cm3) 0.007
LAVmin (cm3) b0.0001 0.002
LAVimax (cm3/m2) 0.11
LAVimin (cm3/m2) 0.03
LA ejection fraction (%) 0.02
PWD
E (cm/s) b0.0001
Deceleration time (sec) 0.76




E′ lateral (cm) 0.11
E′ septal (cm) 0.71
E′ avg. (cm) 0.16
E/E′ lateral 0.001 0.016
E/E′ septal 0.016
E/E′ average 0.001
Abbreviations: LA = left atrium, 4C = four chamber view, 2C = two chamber view,
LAA= LA area, LAV= LA volume, LAVmax=LAmaximumvolume, LAVmin= LAminimum
volume, LAVi = LA volume indexed to body surface area, E = early diastolic transmitral ﬂow
velocity, E′ lateral, septal, avg. are mitral annular velocity at lateral, septal side and average of
them, respectively, E/E′= ratio of early diastolic transmitral ﬂow velocity to mitral annular
motion velocity, PVS=pulmonary vein systolic ﬂow velocity, PVD=pulmonary vein diastolic
ﬂow velocity, PVSD= ratio of PVS to PVD. Signiﬁcance: p b 0.05.
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Clinical characteristics between patients with normal and elevated
LAP are shown in Table 2. BSA and longstanding persistent AF demon-
strated signiﬁcant association with elevated LAP.
3.3. Echocardiographic parameters and mean left atrial pressure
The correlation ofmean LAPwith various TTE parameters of diastolic
function is shown in Table 3 and Fig. 1. Among 2D parameters, LA min-
imum volume (LAVmin) had the strongest correlation with mean LAP
(r = 0.30, p b 0.0001). Among PWD parameters, E (r = 0.31, p b
0.0001), PVS (r= 0.26, p= 0.004) and PVSD (r= 0.24, p= 0.01) dem-
onstrated a signiﬁcant correlation with mean LAP. Among TDI parame-
ters, E/E′ lateral (r= 0.27, p= 0.001), E/E′ septal (r= 0.20, p= 0.016),
and E/E′ average (r = 0.28, p = 0.001) showed signiﬁcant correlation
with LAP. On multiple linear regression analysis, LAVmin (p = 0.002),
PVS (p = 0.01), and E/E′ lateral (p = 0.02) were the best independent
parameters correlated with LAP (r = 0.46).
3.4. Echocardiographic determination of elevated mean left atrial pressure
A number of TTE parameters were found to be signiﬁcantly different
in patients with normal and elevated LAP, shown in Table 4. The most
robust differencewas seen in the same four parameters in linear regres-
sion, namely, LAVmin (56± 18 vs. 72± 27 cm3, p b 0.0001), PVS (49±
16vs. 42±14 cm/s, p=0.006), E (88±20 vs. 99±23 cm/s, p=0.002)
and E/E′ lateral (8.4 ± 3.1 vs. 9.9 ± 4.2, p= 0.008). The result of simple
logistic regression analysis for predictors of elevated LAP is displayed in
Table 5. Among 2D TTE parameters, the strongest predictor of LAP
≥15 mm Hg was LAVmin (p ≤ 0.0001). The strongest PWD parameter
was E (p = 0.01) while PVS (p = 0.02) and PVSD (p = 0.04) were
also signiﬁcant parameters. Among TDI parameters, the strongest pre-
dictors of LAP ≥15mmHgwere E/E′ lateral (p= 0.02) and E/E′ average
(p= 0.03). Using multiple logistic regression, LAVmin (p= 0.001) and
PVS (p=0.015)were found to be the best independent predictors of el-
evated LAPwith an area under the curve (AUC) of 0.72. The second best
logisticmodel included LAVmin (p b 0.001) and E/E′ lateral (p= 0.048)
with an AUC of 0.70. The third best logistic model was LAVmin (p =
0.001) and E (p = 0.035) with an AUC of 0.70.
3.5. Reproducibility
Inter- and intra- observer variability for echocardiographicmeasure-
ments is shown in Table 6. With the exception of the LA diameter
measurements, intra-observer variability was minimal with biases of
0.1% to 5.2%. Inter-observer agreement was excellent with biases of
0.4% to 7.7%.Table 2
Comparison of clinical parameters between patients with normal and elevated left atrial
pressure.
Clinical parameters LAP ≥ 15 mm Hg
(n = 84)
LAP b 15 mm Hg
(n = 73)
p Value
BSA (m2) 2.2 ± 0.3 2.1 ± 0.2 0.030
Age 60.9 ± 8.4 60.5 ± 9.1 0.390
CHADS2 score 1.2 ± 0.9 1.0 ± 0.8 0.060
Gender (male, %) 78 85 0.300
Hypertension (%) 66.7 67.1 0.950
Diabetes mellitus (%) 21.4 10.9 0.078
Coronary artery disease (%) 13.1 12.3 0.886
COPD (%) 5.9 5.5 0.890
Obstructive sleep apnea (%) 27.0 23.3 0.570
Lone AF (%) 10.7 16.4 0.290
Longstanding persistent AF (%) 30.9 13.7 0.010
Abbreviations as in Table 1. Signiﬁcance: p b 0.05.4. Discussion
We investigated the utility of transthoracic echocardiography in
detecting diastolic dysfunction in a large cohort of patients with LVEF
N50% and persistent and longstanding persistent AF using directly mea-
sured LAP as the reference standard. We demonstrated that there is a
modest but signiﬁcant correlation between directly measured LAP and
a number of TTE parameters including the LAVmin, PVS, E and E/E′
lateral.
4.1. Correlation between elevated left atrial pressure and clinical parameters
We found a signiﬁcant correlation between body surface area and
longstanding persistent AF and elevated LAP. The duration of atrial ar-
rhythmia may contribute to an increase in atrial afterload through de-
creasing coordinated atrial contractions which leads to atrial ﬁbrosis.
Patients with longstanding persistent AF have higher LAP as the result
of atrial remodeling. Obesity may also cause elevated LA pressure
through atrial remodeling [14].
4.2. LA minimal volume and left atrial pressure
LAVminwas shown to identify themeanpulmonarywedge pressure
N12 mm Hg in patients with coronary artery disease [15]. Our study
showed that among 2D TTE parameters, LAVmin had the strongest cor-
relation with LAP. LA size is known to be a predictor of adverse clinical
outcomes [16], although LAVmax rather than LAVmin is generally
used to assess LA size [17]. However, LAVmax is inﬂuenced by atrio-
ventricular mechanical coupling. Both mechanical traction of the LV
longitudinal ﬁbers and the twisting motion of LV during systole cause
Fig. 1. Scatter plots ofmean left atrial pressure to TTE parameterswith the strongest correlation. A. Left atrialminimumvolume (p b 0.0001). B. Peak early diastolic transmitral inﬂow (p=
0.002). C. Pulmonary vein systolic ﬂow (p = 0.006). D. E/E′ lateral (p = 0.008).
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the pulmonary veins [18,19]. Conversely, during early diastole,
untwisting of the LV contributes to LV ﬁlling [20], and in end-diastole
when themitral valve is open, the LA is directly exposed to the LV pres-
sure. Therefore, LA volume at end LV diastole may be the measurement
that best reﬂects LA size independent of atrio-ventricular coupling
mechanics. Indeed, recent work has shown that LAVmin as measured
by real-time 3-D echocardiography is more strongly correlated to LV
diastolic function and LV ﬁlling pressure than LAVmax in patients with
sinus rhythm [21]. Furthermore, LAVmin was shown to be a robust in-
dependent predictor of ﬁrst AF and ﬁrst atrial ﬂutter in an elderly cohort
[22]. Nevertheless, to date,most studies have focused on LA end-systolic
volume. Our studyhas extended the importance of LAVmin to a group of
persistent and longstanding persistent AF patients where LAVmin had a
stronger correlation than LAVmax with mean LAP.
4.3. Pulsed wave Doppler parameters (E and PVS) and mean left atrial
pressure
Transmitral E velocity is the rapid early diastolic left ventricular in-
ﬂow velocity that occurs with the mitral valve opening and was
shown to have modest correlation with LV ﬁlling pressure in AF [23].
High E velocity may be found in either young patients with normal re-
laxation and low LV ﬁlling pressures, or in patients with elevated LV ﬁll-
ing pressures in the setting of abnormal relaxation without signiﬁcant
mitral regurgitation [24]. In our study, we found a modest, signiﬁcant
correlation between directly measured LAP and E. We also found that
PVS correlated with directly measured LAP in our cohort of patients.Previous studies have demonstrated a correlation between PVS and
LAP in patients without AF [25] but the utility of PVS for detecting DD
in patients with persistent AF has not been previously reported. Systolic
ﬂow from the pulmonary veins into the left atrium is affected by a
number of factors including atrial relaxation, atrial compliance, atrial
pressure, mitral regurgitation, and LV systolic function. We excluded
patients with impaired LV systolic function as well as patients with
moderate or severe mitral regurgitation, hence our observation that
PVS is correlated with LAP is based primarily on LA diastolic function.
4.4. E/E′ lateral and mean left atrial pressure
E/E′ is useful in assessing elevated LV ﬁlling pressure in patients in
sinus rhythm [7,8]. It has been shown on small series that E/E′ is
prognostically important in patients with non-valvular AF [26] and
that it may be useful for the detection of elevated LAP in patients with
AF [9,27]. Our study used directly measured LAP as the reference stan-
dard and showed that E/E′was not the best single non-invasive param-
eter to predict diastolic dysfunction in this large cohort of patients with
persistent AF. Together with LAVmin and PVS, E/E′ lateral was the best
independent parameters that correlated with LAP, but the cutoff value
was difﬁcult to determine. In light of recent data showing that the rela-
tionship between non-invasive indices and the pulmonary wedge pres-
sure is highly variable in patients with heart failure with preserved
ejection fraction [28], the limited correlation of E/E′ to mean LAP that
we observed in this cohort of non heart failure patients with preserved
EF raises the question regarding the importance of E/E′ in patients with
persistent AF.
Table 4
Comparison of echocardiographic parameters between patients with normal and elevated
left atrial pressure.
Echocardiographic parameters LAP ≥ 15 mm Hg
(n = 84)




LA diameter (mm) 42.6 ± 11.8 40.0 ± 11.8 0.145
LAA maximum (4C, cm2) 25.5 ± 5.7 23.2 ± 4.5 0.004
LAA minimum (4C, cm2) 19 ± 5.4 17 ± 3.8 0.004
LA max. length (4C, cm) 5.4 ± 0.6 5.3 ± 0.6 0.037
LA min length (4C, cm) 4.6 ± 0.6 4.5 ± 0.6 0.210
LAA maximum (2C, cm2) 25.5 ± 5.4 23.0 ± 4.2 0.001
LAA minimum (2C, cm2) 19.4 ± 4.7 17.0 ± 4.1 0.001
LA max. length (2C, cm) 5.5 ± 0.7 5.1 ± 0.6 b0.0001
LA min length (2C, cm) 4.7 ± 0.6 4.4 ± 0.6 b 0.0001
LAVmax (cm3) 107 ± 36 89 ± 23 b0.0001
LAVmin (cm3) 72 ± 27 56 ± 18 b0.0001
LAVimax (cm3/m2) 48 ± 16 42 ± 11 0.008
LAVimin (cm3/m2) 32 ± 13 27 ± 8 0.004
LA ejection fraction (%) 33 ± 11 37 ± 13 0.010
PWD
E (cm/s) 99 ± 23 88 ± 20 0.002
Deceleration time (sec) 200 ± 4 198 ± 5 0.390
PVS (cm/s) 42 ± 2 49 ± 2 0.006
PVD (cm/s) 65 ± 2 66 ± 3 0.380
PVSD 0.68 ± 0.03 0.79 ± 0.04 0.020
TDI
E′ lateral (cm) 10.9 ± 2.9 11.4 ± 3.1 0.150
E′ septal (cm) 9.5 ± 2.7 9.1 ± 2.7 0.170
E′ avg. (cm) 10.0 ± 2.6 10.2 ± 2.5 0.290
E/E′ lateral 9.9 ± 4.1 8.4 ± 3.1 0.008
E/E′ septal 11.4 ± 4.6 10.7 ± 3.8 0.180
E/E′ average 10.8 ± 4.3 9.3 ± 3.1 0.010
Abbreviations as in Table 3. Signiﬁcance: p b 0.05.
Table 6
Intra- and inter-observer variability.
Parameters Intra-observer Inter-observer
R Difference (%) R Difference (%)
2D
LA diameter 0.70 4.50 0.60 1.30
LAA maximum (4C) 0.97 5.20 0.90 6.70
LAA maximum (2C) 0.90 2.50 0.80 0.40
LAVmax 0.90 0.80 0.80 2.40
LAVmin 0.80 1.50 0.80 7.70
PWD
E 0.90 2.50 0.96 1.40
Decel time 0.90 0.10 0.90 2.50
PVS 0.90 2.70 0.95 3.30
PVD 0.95 0.96 0.97 3.70
TDI
E′ lateral 0.98 2.60 0.98 3.60
E′ septal 0.97 1.97 0.90 3.30
Abbreviations as in Table 3.
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An important limitation of this study is that the direct LAPmeasure-
ments were obtained prior to PVI, whereas TTE assessment of diastolicTable 5
Correlation of TTE parameters with LAP ≥15 mm Hg.
Echocardiographic parameters Univariate logistic regression
(LAP ≥ 15 mm Hg)
p OR [95% CI]
2D
LA diameter 0.291 0.98 [0.96–1.0]
LAA maximum (4C) 0.010 1.10 [1.02–1.2]
LAA minimum (4C) 0.010 1.10 [1.02–1.2]
LA max. length (4C) 0.076 1.60 [0.95–2.7]
LA min length (4C) 0.421 1.24 [0.73–2.1]
LAA maximum (2C) 0.004 1.11 [1.03–1.2]
LAA minimum (2C) 0.002 1.14 [1.05–1.23]
LA max. length (2C) 0.001 2.54 [1.45–4.46]
LA min length (2C) 0.001 2.78 [1.54–5.03]
LAVmax 0.001 1.02 [1.00–1.04]
LAVmin b0.0001 1.03 [1.02–1.05]
LAVimax 0.019 1.03 [1.01–1.06]
LAVimin 0.010 1.05 [1.01–1.08]
LA ejection fraction 0.031 0.97 [0.94–1.00]
PWD
E 0.005 1.02 [1.0–1.04]
Deceleration time 0.794 1.00 [1.0–1.01]
PVS 0.016 0.97 [0.95–1.0]
PVD 0.756 1.00 [0.98–1.02]
PVSD 0.044 0.25 [0.06–0.96]
TDI
E′ lateral 0.307 0.94 [0.84–1.05]
E′ septal 0.352 1.06 [0.94–1.20]
E′ avg. 0.595 0.97 [0.85–1.09]
E/E′ lateral 0.022 1.13 [1.02–1.25]
E/E′ septal 0.363 1.04 [0.96–1.12]
E/E′ average 0.025 1.12 [1.01–1.23]
Abbreviations as in Table 3. Signiﬁcance: p b 0.05.function was performed after PVI when the patients were in sinus
rhythm. In this cohort of patients, we had 4 patients who had LAP
measured both prior and immediately post ablation and there was no
statistical difference (p= 0.49) between the twomeasurements. In ad-
dition, we also had 8 patients who had pre-procedural echocardiogram
(the day prior to the procedure) and the ﬁrst post-procedural day
echocardiogram and there was no statistical difference in all measured
echocardiographic parameters. It is also reported that atrial electrical–
mechanical recoupling and reverse atrial remodeling does not occur im-
mediately after cardioversion or radiofrequency ablation [29]. Therefore
it is reasonable to assume that TTE parametersmeasured on theﬁrst day
following PVI reﬂect values similar to what would have been obtained
prior to PVI. Our study population was predominantly male and the
results may not be applicable on female patients with persistent AF.
6. Conclusion
Assessment of diastolic function in patients with AF is challenging.
Patients with longstanding persistent AF are at higher risk of having
elevated LAP. LAVmin is the single best echocardiographic parameter
to indicate elevated LAP with directly measured LAP as a reference
standard in non heart failure patients with persistent and longstanding
persistent AF and preserved ejection fraction. Combining 2D, PWD, and
TDI parameters, it is possible to have a modest assessment of diastolic
function in these patients.
Author contributions
Concept/design: MK, YH, DJC.
Data collection: MK, EZ, LG.
Data analysis/interpretation: MK, YH, DRO.
Drafting article: MK.
Critical revision of article: YH, EZ, FEM, DJC.
Approval of article: MK, YH, EZ, FEM, DJC, LG, DRO.
Statistics: MK, YH.
Funding secured by: MK, FEM, YH.
Conﬂict of interest
The authors report no relationships that could be construed as a
conﬂict of interest.
References
[1] E. Braunwald, Shattuck lecture—cardiovascular medicine at the turn of themillenni-
um: triumphs, concerns, and opportunities, N. Engl. J. Med. 337 (1997) 1360–1369.
94 M. Kohári et al. / IJC Heart & Vasculature 9 (2015) 89–94[2] T.J. Wang, M.G. Larson, D. Levy, R.S. Vasan, E.P. Leip, P.A. Wolf, et al., Temporal rela-
tions of atrial ﬁbrillation and congestive heart failure and their joint inﬂuence on
mortality: the Framingham Heart Study, Circulation 107 (2003) 2920–2925.
[3] A.B. Miller, I.L. Pina, Understanding heart failure with preserved ejection fraction:
clinical importance and future outlook, Congest. Heart Fail. 15 (2009) 186–192.
[4] T.S. Tsang, B.J. Gersh, C.P. Appleton, A.J. Tajik, M.E. Barnes, K.R. Bailey, et al., Left
ventricular diastolic dysfunction as a predictor of the ﬁrst diagnosed nonvalvular
atrial ﬁbrillation in 840 elderly men and women, J. Am. Coll. Cardiol. 40 (2002)
1636–1644.
[5] R. Nagarakanti, M. Ezekowitz, Diastolic dysfunction and atrial ﬁbrillation, J. Interv.
Card. Electrophysiol. 22 (2008) 111–118.
[6] R. Parkash,W.H. Maisel, F.M. Toca, W.G. Stevenson, Atrial ﬁbrillation in heart failure:
highmortality risk even if ventricular function is preserved, Am. Heart J. 150 (2005)
701–706.
[7] S.R. Ommen, R.A. Nishimura, C.P. Appleton, F.A. Miller, J.K. Oh, M.M. Redﬁeld, et al.,
Clinical utility of Doppler echocardiography and tissue Doppler imaging in the
estimation of left ventricular ﬁlling pressures: a comparative simultaneous
Doppler-catheterization study, Circulation 102 (2000) 1788–1794.
[8] M. Kasner, D.Westermann, P. Steendijk, R. Gaub, U.Wilkenshoff, K.Weitmann, et al.,
Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of
diastolic function in heart failure with normal ejection fraction: a comparative
Doppler-conductance catheterization study, Circulation 116 (2007) 637–647.
[9] D.W. Sohn, J.M. Song, J.H. Zo, I.H. Chai, H.S. Kim, H.G. Chun, et al., Mitral annulus
velocity in the evaluation of left ventricular diastolic function in atrial ﬁbrillation,
J. Am. Soc. Echocardiogr. 12 (1999) 927–931.
[10] T. Watanabe, M. Iwai-Takano, M. Oikawa, T. Yamaki, H. Yaoita, Y. Maruyama,
Optimal noninvasive assessment of diastolic heart failure in patients with atrial
ﬁbrillation: comparison of tissue Doppler echocardiography, left atrium size, and
brain natriuretic peptide, J. Am. Soc. Echocardiogr. 21 (2008) 689–696.
[11] H. Calkins, K.H. Kuck, R. Cappato, J. Brugada, A.J. Camm, S.A. Chen, et al., 2012 HRS/
EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial
ﬁbrillation: recommendations for patient selection, procedural techniques, patient
management and follow-up, deﬁnitions, endpoints, and research trial design: a re-
port of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Abla-
tion of Atrial Fibrillation. Developed in partnership with the European Heart
Rhythm Association (EHRA), a registered branch of the European Society of Cardiol-
ogy (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collabora-
tion with the American College of Cardiology (ACC), American Heart Association
(AHA), the Asia Paciﬁc Heart Rhythm Society (APHRS), and the Society of Thoracic
Surgeons (STS). Endorsed by the governing bodies of the American College of
Cardiology Foundation, the American Heart Association, the European Cardiac
Arrhythmia Society, the European Heart RhythmAssociation, the Society of Thoracic
Surgeons, the Asia Paciﬁc Heart Rhythm Society, and the Heart Rhythm Society,
Heart Rhythm. 9 (2012) 632–696 e21.
[12] P. Leong-Sit, E. Zado, D.J. Callans, F. Garcia, D. Lin, S. Dixit, et al., Efﬁcacy and risk of
atrial ﬁbrillation ablation before 45 years of age, Circ. Arrhythm. Electrophysiol. 3
(2010) 452–457.
[13] S. Dixit, F.E. Marchlinski, D. Lin, D.J. Callans, R. Bala, M.P. Riley, et al., Randomized
ablation strategies for the treatment of persistent atrial ﬁbrillation: RASTA study,
Circ. Arrhythm. Electrophysiol. 5 (2012) 287–294.
[14] Y.K. Iwasaki, Y. Shi, B. Benito, M.A. Gillis, K. Mizuno, J.C. Tardif, et al., Determinants of
atrial ﬁbrillation in an animal model of obesity and acute obstructive sleep apnea,
Heart Rhythm. 9 (2012) 1409–1416 e1.[15] C.P. Appleton, J.M. Galloway, M.S. Gonzalez, M. Gaballa, M.A. Basnight, Estimation of
left ventricular ﬁlling pressures using two-dimensional and Doppler echocardiogra-
phy in adult patients with cardiac disease. Additional value of analyzing left atrial
size, left atrial ejection fraction and the difference in duration of pulmonary venous
and mitral ﬂow velocity at atrial contraction, J. Am. Coll. Cardiol. 22 (1993)
1972–1982.
[16] T.S. Tsang, M.E. Barnes, B.J. Gersh, K.R. Bailey, J.B. Seward, Left atrial volume as a
morphophysiologic expression of left ventricular diastolic dysfunction and relation
to cardiovascular risk burden, Am. J. Cardiol. 90 (2002) 1284–1289.
[17] R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, et al.,
Recommendations for chamber quantiﬁcation: a report from the American Society
of Echocardiography's Guidelines and Standards Committee and the Chamber
Quantiﬁcation Writing Group, developed in conjunction with the European Associ-
ation of Echocardiography, a branch of the European Society of Cardiology, J. Am.
Soc. Echocardiogr. 18 (2005) 1440–1463.
[18] R. Castello, A.C. Pearson, P. Lenzen, A.J. Labovitz, Evaluation of pulmonary venous
ﬂow by transesophageal echocardiography in subjects with a normal heart: com-
parison with transthoracic echocardiography, J. Am. Coll. Cardiol. 18 (1991) 65–71.
[19] P. Barbier, S.B. Solomon, N.B. Schiller, S.A. Glantz, Left atrial relaxation and left ven-
tricular systolic function determine left atrial reservoir function, Circulation 100
(1999) 427–436.
[20] S.F. Nagueh, C.P. Appleton, T.C. Gillebert, P.N. Marino, J.K. Oh, O.A. Smiseth, et al.,
Recommendations for the evaluation of left ventricular diastolic function by
echocardiography, J. Am. Soc. Echocardiogr. 22 (2009) 107–133.
[21] C. Russo, Z. Jin, S. Homma, T. Rundek, M.S. Elkind, R.L. Sacco, et al., Left atrial
minimum volume and reservoir function as correlates of left ventricular diastolic
function: impact of left ventricular systolic function, Heart 98 (2012) 813–820.
[22] K. Fatema, M.E. Barnes, K.R. Bailey, W.P. Abhayaratna, S. Cha, J.B. Seward, et al.,
Minimum vs. maximum left atrial volume for prediction of ﬁrst atrial ﬁbrillation
or ﬂutter in an elderly cohort: a prospective study, Eur. J. Echocardiogr. 10 (2009)
282–286.
[23] S.F. Nagueh, H.A. Kopelen, M.A. Quinones, Assessment of left ventricular ﬁlling
pressures by Doppler in the presence of atrial ﬁbrillation, Circulation 94 (1996)
2138–2145.
[24] M.J. Garcia, J.D. Thomas, A.L. Klein, New Doppler echocardiographic applications for
the study of diastolic function, J. Am. Coll. Cardiol. 32 (1998) 865–875.
[25] H.F. Kuecherer, I.A. Muhiudeen, F.M. Kusumoto, E. Lee, L.E. Moulinier, M.K. Cahalan,
et al., Estimation of mean left atrial pressure from transesophageal pulsed Doppler
echocardiography of pulmonary venous ﬂow, Circulation 82 (1990) 1127–1139.
[26] H. Okura, Y. Takada, T. Kubo, K. Iwata, S. Mizoguchi, H. Taguchi, et al., Tissue
Doppler-derived index of left ventricular ﬁlling pressure, E/E′, predicts survival of
patients with non-valvular atrial ﬁbrillation, Heart 92 (2006) 1248–1252.
[27] K. Kusunose, H. Yamada, S. Nishio, N. Tomita, T. Niki, K. Yamaguchi, et al., Clinical
utility of single-beat E/e′ obtained by simultaneous recording of ﬂow and tissue
Doppler velocities in atrial ﬁbrillation with preserved systolic function, JACC
Cardiovasc. Imaging 2 (2009) 1147–1156.
[28] P.S. Bhella, E.L. Pacini, A. Prasad, J.L. Hastings, B. Adams-Huet, J.D. Thomas, et al.,
Echocardiographic indices do not reliably track changes in left-sided ﬁlling pressure
in healthy subjects or patients with heart failure with preserved ejection fraction,
Circ. Cardiovasc. Imaging 4 (2011) 482–489.
[29] P. Reant, S. Laﬁtte, P. Jais, K. Serri, R. Weerasooriya, M. Hocini, et al., Reverse remod-
eling of the left cardiac chambers after catheter ablation after 1 year in a series of
patients with isolated atrial ﬁbrillation, Circulation 112 (2005) 2896–2903.
